Interleukin Genetics (ILIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 2,514 | 1,441 | 1,810 | 2,430 | 2,236 |
| Cost of Goods | 1,602 | 1,414 | 1,435 | 1,633 | 1,329 |
| Gross Profit | 912 | 27 | 375 | 797 | 908 |
| Operating Expenses | 8,187 | 7,730 | 7,140 | 8,028 | 5,907 |
| Operating Income | -6,674 | -7,289 | -6,329 | -6,599 | -4,670 |
| Interest Expense | 741 | 610 | 11 | 472 | 455 |
| Other Income | 0 | 0 | 5 | 13 | 5 |
| Pre-tax Income | -7,414 | -7,898 | -6,336 | -7,058 | -5,120 |
| Net Income Continuous | -7,414 | -7,898 | -6,336 | -7,058 | -5,120 |
| Net Income | $-7,414 | $-7,898 | $-6,336 | $-7,058 | $-5,120 |
| EPS Basic Total Ops | -0.04 | -0.05 | -0.05 | -0.08 | -0.14 |
| EPS Basic Continuous Ops | -0.04 | -0.05 | -0.05 | -0.08 | -0.14 |
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.05 | -0.08 | -0.14 |
| EPS Diluted Continuous Ops | -0.04 | -0.05 | -0.05 | -0.08 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.05 | -0.05 | -0.08 | -0.14 |
| EBITDA(a) | $-6,251 | $-6,831 | $-6,066 | $-6,369 | $-4,388 |